إعلان
إعلان

USNA

USNA logo

USANA Health Sciences Inc

19.43
USD
برعاية
-0.20
-0.99%
٠٢ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

19.43

0.00
-0.03%

تقارير أرباح USNA

النسبة الإيجابية المفاجئة

USNA تفوق 23 من 39 آخر التقديرات.

59%

التقرير التالي

بيانات التقرير القادم
٢٣ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$225.20M
/
$0.40
التغير الضمني من Q3 25 (Revenue/ EPS)
+5.24%
/
-366.67%
التغير الضمني من Q4 24 (Revenue/ EPS)
+5.43%
/
-37.50%

USANA Health Sciences Inc earnings per share and revenue

On ٠٩ أكتوبر ٢٠٢٥, USNA reported earnings of -0.15 USD per share (EPS) for Q3 25, missing the estimate of 0.47 USD, resulting in a -131.29% surprise. Revenue reached 214.00 مليون, compared to an expected 228.61 مليون, with a -6.39% difference. The market reacted with a -22.79% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of 0.40 USD, with revenue projected to reach 225.20 مليون USD, implying an decrease of -366.67% EPS, and increase of 5.24% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Pharmaceuticals Inc. Common
Report Date
٢٦ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.49
الفعلي
-
مفاجئة
-
الأسئلة الشائعة
For Q3 2025, USANA Health Sciences Inc reported EPS of -$0.15, missing estimates by -131.29%, and revenue of $214.00M, -6.39% below expectations.
The stock price moved down -22.79%, changed from $26.24 before the earnings release to $20.26 the day after.
The next earning report is scheduled for ٢٣ فبراير ٢٠٢٦.
Based on 3 analysts, USANA Health Sciences Inc is expected to report EPS of $0.40 and revenue of $225.20M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان